• News
  • Stock Screener
  • Small Caps
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Review
  • X (Twitter)
  • LinkedIn

Stock Screener

Show:
Sort
Country
Sector
Risk rating
1
2
3
4
5
6
7
Risk factors

    Default risk

    1
    2
    3
    4
    5
    6
    7

    Volatility

    1
    2
    3
    4
    5
    6
    7

    Stress test

    1
    2
    3
    4
    5
    6
    7

    Selling difficulty

    1
    2
    3
    4
    5
    6
    7

    Country risks

    1
    2
    3
    4
    5
    6
    7

    Other risks

    1
    2
    3
    4
    5
    6
    7
Profitability factors

    Valuation

    1
    2
    3
    4
    5
    6
    7

    Analyst view

    1
    2
    3
    4
    5
    6
    7

    Performance

    1
    2
    3
    4
    5
    6
    7

    Profitability

    1
    2
    3
    4
    5
    6
    7

    Growth

    1
    2
    3
    4
    5
    6
    7

    Dividends

    1
    2
    3
    4
    5
    6
    7
    Results: 200

    Caliway Biopharmaceuticals Co., Ltd.

    6919.TWO
    1

    PharmaEssentia Corporation

    6446.TW
    4

    Lotus Pharmaceutical Co., Ltd.

    1795.TW
    5

    Bora Pharmaceuticals Co., LTD.

    6472.TW
    7

    Lin BioScience, Inc.

    6696.TWO
    2

    Oneness Biotech Co., Ltd.

    4743.TWO
    4

    Center Laboratories, Inc.

    4123.TWO
    4

    Pell Bio-Med Technology Co., Ltd.

    6949.TW
    1

    AP Biosciences Inc

    6945.TWO
    1

    Pegavision Corporation

    6491.TW
    5

    TaiGen Biopharmaceuticals Holdings Limited

    4157.TWO
    2

    EirGenix Inc.

    6589.TWO
    2

    BIONET Corp.

    1784.TWO
    3

    Adimmune Corporation

    4142.TW
    3

    Medeon Biodesign, Inc.

    6499.TWO
    3

    Medigen Vaccine Biologics Corporation

    6547.TWO
    1

    Handa Pharmaceuticals, Inc.

    6620.TWO
    3

    Alar Pharmaceuticals Inc.

    6785.TWO
    3

    TTY Biopharm Company Limited

    4105.TWO
    6

    Genovate Biotechnology Co., Ltd.

    4130.TWO
    3
    Show more
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2025